recurrent depressive disorder, currently in remission相关文献:
Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression.
Reif A, Bitter I, Buyze J, Cebulla K, Frey R, Fu DJ, Ito T, Kambarov Y, Llorca PM, Oliveira-Maia AJ, Messer T, Mulhern-Haughey S, Rive B, von Holt C, Young AH, Godinov Y; ESCAPE-TRD Investigators.
N Engl J Med. 2023 Oct 5;389(14):1298-1309. doi: 10.1056/NEJMoa2304145.
PMID:37792613
Brain stimulation treatment for bipolar disorder.
Mutz J.
Bipolar Disord. 2023 Feb;25(1):9-24. doi: 10.1111/bdi.13283. Epub 2022 Dec 21.
PMID:36515461
Cognitive dysfunctions in depression - significance, description and treatment prospects.
Czerwińska A, Pawłowski T.
Psychiatr Pol. 2020 Jun 30;54(3):453-466. doi: 10.12740/PP/OnlineFirst/105415. Epub 2020 Jun 30.
PMID:33038880
The sequenced treatment alternatives to relieve depression (STAR*D) trial: a review.
Sinyor M, Schaffer A, Levitt A.
Can J Psychiatry. 2010 Mar;55(3):126-35. doi: 10.1177/070674371005500303.
PMID:20370962
Efficacy of Mindfulness-Based Cognitive Therapy in Prevention of Depressive Relapse: An Individual Patient Data Meta-analysis From Randomized Trials.
Kuyken W, Warren FC, Taylor RS, Whalley B, Crane C, Bondolfi G, Hayes R, Huijbers M, Ma H, Schweizer S, Segal Z, Speckens A, Teasdale JD, Van Heeringen K, Williams M, Byford S, Byng R, Dalgleish T.
JAMA Psychiatry. 2016 Jun 1;73(6):565-74. doi: 10.1001/jamapsychiatry.2016.0076.
PMID:27119968
Cognitive performance in antidepressant-free recurrent major depressive disorder.